Nurix Therapeutics Inc
(NRIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 11/30
| 02-2021 | 11-2020 | 08-2020 | 05-2020 | 02-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -24,275 | -43,242 | -23,328 | -4,811 | -12,391 |
| Depreciation Amortization | 1,607 | 2,453 | 1,666 | 1,036 | 499 |
| Accounts payable and accrued liabilities | 899 | 1,234 | 602 | 1,745 | 298 |
| Other Working Capital | 28,021 | 36,408 | 40,299 | 29,668 | 52,688 |
| Other Operating Activity | 1,801 | 3,067 | 1,163 | -1,095 | -122 |
| Operating Cash Flow | $8,053 | $-80 | $20,402 | $26,543 | $40,972 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -843 | -4,553 | -3,647 | -1,977 | -364 |
| Purchase Of Investment | -47,742 | -275,224 | -141,067 | -29,640 | -19,060 |
| Sale Of Investment | 46,198 | 25,373 | 14,873 | 9,857 | N/A |
| Investing Cash Flow | $-2,387 | $-254,404 | $-129,841 | $-21,760 | $-19,424 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,360 | 219,117 | 220,238 | 177 | 47 |
| Common Stock Repurchased | -1 | -7 | -2 | -1 | -1 |
| Other Financing Activity | 0 | 119,914 | 119,914 | 119,554 | 0 |
| Financing Cash Flow | $1,359 | $339,024 | $340,150 | $119,730 | $46 |
| Beginning Cash Position | 119,526 | 34,986 | 34,986 | 34,986 | 34,986 |
| End Cash Position | 126,551 | 119,526 | 265,697 | 159,499 | 56,580 |
| Net Cash Flow | $7,025 | $84,540 | $230,711 | $124,513 | $21,594 |
| Free Cash Flow | |||||
| Operating Cash Flow | 8,053 | -80 | 20,402 | 26,543 | 40,972 |
| Capital Expenditure | -843 | -4,553 | -3,647 | -1,977 | -364 |
| Free Cash Flow | 7,210 | -4,633 | 16,755 | 24,566 | 40,608 |